Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02781051 · ClinicalTrials.gov registry record · NA

Increasing Physical Activity Among Breast Cancer Survivors With Depression

A NA study of Breast Cancer and Depression, sponsored by University of Texas Southwestern Medical Center.

Completed
Registry status
NA
Development phase
16
Enrollment target
1
Study location

NCT02781051 is a NA study of Breast Cancer and Depression that has completed, run by University of Texas Southwestern Medical Center. The registered enrollment target is 16 participants, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02781051, a NA study of Breast Cancer and Depression, has completed, sponsored by University of Texas Southwestern Medical Center.

COMPLETED
Registry status
NA
Development phase
16 participants
Enrollment target
1
Study location

Study Summary

Pilot study to assess a multi-component intervention to increase physical activity among breast cancer survivors with depression.

Interventions

  • DEVICE Fitbit
  • BEHAVIORAL Print-based education
  • BEHAVIORAL Active Living counseling
  • OTHER Facility Access

Study Locations (1)

Texas

  • UT Southwestern Medical Center - Dallas

Trial Details

FieldValue
Enrollment Target 16 participants
Start Date 2016-05
Est. Completion 2017-09
Phase NA

What the Registry Record Tells You About NCT02781051

The ClinicalTrials.gov registry entry for NCT02781051 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (99% lower). The listed sponsor is University of Texas Southwestern Medical Center, which has 837 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Breast Cancer appearing as the primary indexed condition, and to 4 interventions - of which Fitbit is the first listed.

NCT02781051 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT02781051 about?

NCT02781051 is a clinical study titled "Increasing Physical Activity Among Breast Cancer Survivors With Depression". Pilot study to assess a multi-component intervention to increase physical activity among breast cancer survivors with depression.

What is the current status of trial NCT02781051?

This trial is currently completed. It is a NA study. The enrollment target is 16 participants. The study started on 2016-05. Estimated completion is 2017-09.

What conditions does trial NCT02781051 study?

This clinical trial studies the following conditions: Breast Cancer, Depression, Physical Activity.

What interventions are being tested in trial NCT02781051?

The interventions under investigation include: Fitbit (DEVICE), Print-based education (BEHAVIORAL), Active Living counseling (BEHAVIORAL), Facility Access (OTHER).

Who is sponsoring clinical trial NCT02781051?

This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02781051 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Breast Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.